NVIDIA GTC Paris at VivaTech - NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.

Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...

Shares in Nvidia (NVDA) rose nearly 3% in pre-market trading on Thursday after the company announced a $5bn investment in fellow chipmaker Intel (INTC). Nvidia (NVDA) said it will invest $5bn in Intel ...

Novo Nordisk(NYSE: NVO) is in the spotlight after cutting guidance again, but analysts remain optimistic. With Ozempic and Wegovy driving strong sales and a 52% upside potential, this could be one of ...

Novo Nordisk's softening sales performance, which prompted restructuring, has resulted in significantly reduced profit ...

Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity ...

Newly-elected chairman of Wegovy-maker Novo Nordisk , Lars Rebien Sorensen, said on Friday he plans to enhance the board's ...